abiraterone,olaparib
astrazeneca,merck
[]
 this is a great trial. but it doesn't really seem right to highlight a "trend" in non-hrrm patients when the hr is 0.89 and ci including 1 and then some...
Urologic oncology & epidemiology focused on #prostatecancer. @UCSFcancer @UCSFurology. GU Chief @SFVAMC. Married fellow #foodiedoc @dolevderm. Many opinions :)